Clinical differences between idiopathic and scleroderma‐related pulmonary hypertension
Top Cited Papers
- 31 August 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (9) , 3043-3050
- https://doi.org/10.1002/art.22069
Abstract
Objective Pulmonary arterial hypertension related to scleroderma (PAH‐Scl) is associated with high morbidity and mortality as well as poorer response to therapy and worse outcomes compared with the idiopathic form of PAH (IPAH). Scleroderma is an autoimmune disease that can affect left and right heart function directly through inflammation and fibrosis and indirectly through systemic and pulmonary hypertension. This study tested the hypothesis that an increased prevalence of left heart disease might explain the higher mortality in patients with PAH‐Scl compared with patients with IPAH. Methods The study was designed as a retrospective cohort study comparing the baseline clinical data from 91 consecutive patients (41 with IPAH and 50 with PAH‐Scl). Cox proportional hazards models were used to predict the effect of clinical covariates on patient survival. Results Patients with PAH‐Scl had a lower mean pulmonary artery pressure (46.6 mm Hg versus 54.4 mm Hg in patients with IPAH; P = 0.002) despite similar levels of cardiac dysfunction (cardiac index 2.2 and 2.1 liters/minute/m2, respectively; P = 0.19). Echocardiography revealed similar degrees of right ventricular dysfunction in the 2 groups, whereas a predominance of left heart dysfunction was observed in patients with PAH‐Scl. One‐ and three‐year survival estimates were 87.8% and 48.9%, respectively, in patients with PAH‐Scl and 95.1% and 83.6%, respectively, in those with IPAH. Patients with PAH‐Scl were 3.06 times more likely to die than were patients with IPAH, after controlling for the presence of pericardial effusion; there was no significant change in increased risk of death in PAH‐Scl after controlling for left heart disease. Conclusion The results confirm that there are significant clinical and survival differences between IPAH and PAH‐Scl. The presence of left heart disease, although more common in PAH‐Scl, was not predictive of the higher mortality in these patients.Keywords
This publication has 34 references indexed in Scilit:
- Systemic sclerosis associated pulmonary hypertension: improved survival in the current eraHeart, 2006
- Comparison of Usefulness of Echocardiographic Doppler Variables to Left Ventricular End-Diastolic Pressure in Predicting Future Heart Failure EventsThe American Journal of Cardiology, 2006
- Diastolic Heart Failure Can Be Diagnosed by Comprehensive Two-Dimensional and Doppler EchocardiographyJournal of the American College of Cardiology, 2006
- The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community‐based rheumatologists (the UNCOVER study)Arthritis & Rheumatism, 2005
- Clinical classification of pulmonary hypertensionPublished by Elsevier ,2004
- Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approachAnnals of the Rheumatic Diseases, 2003
- Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US populationArthritis & Rheumatism, 2003
- Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertensionThe American Journal of Cardiology, 1999
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- The production of acute pericardial effusion: The effects of various degrees of interference with venous blood and lymph drainage from the heart muscle in the dogThe American Journal of Cardiology, 1971